Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 28 of the 40 sources its claims cite were checked for support.
Abstract
The Covid-19 pandemic had a profound effect on the delivery of healthcare research. This study explores the engagement experiences of trial participants’, PPIE contributors’ and trial staff during the Covid-19 pandemic and towards recovery and restoring a diverse and balanced UK clinical trials portfolio including oral and dental health trials.
Overview
CoChat Summary
## TL;DR
This qualitative NIHR study interviewed PPIE contributors, trial participants, and trial staff across multiple specialties to understand what helped or hindered trial engagement during COVID-19. It found three main facilitators: continued contact and communication, a balanced use of remote methods, and clear information that helped people feel safe and informed.
## Key findings
- The study recruited 106 participants: 45 PPIE contributors, 27 trial participants, and 34 trial staff members.
- Thematic analysis produced 3 themes: ensuring continued contact, a balanced move to remote consultations, and the importance of feeling fully informed / safe and informed of new rules.
- Continued contact supported engagement and retention: telephone, emails, texts, and postal letters were used, with telephone described as a key facilitator; regular updates helped participants feel more engaged and less “left in the dark.”
- Remote consultations were often valued for convenience, keeping participants in the trial, and enabling wider UK recruitment, but barriers included loss of personal contact, communication limits, missed diagnoses, and technical problems, especially for older or disadvantaged participants.
- Feeling informed and safe mattered: participants wanted clear, detailed information about what would happen, Covid-19 precautions, and site rules; safety measures such as PPE, distancing, one-way systems, cleanliness, and clear signage increased confidence.
## Methods
- Design: Qualitative study using semi-structured interviews and focus groups with PPIE contributors, trial participants, and trial staff from NIHR-funded/CRN portfolio studies across the UK.
- Sample/data: Participants were recruited from multiple specialties including Cancer, Oral and Dental Health, Musculoskeletal Disorders, Cardiovascular Disease, Neurological Disorders, Primary Care, and conditions associated with susceptibility to Covid-19 (Diabetes, Stroke, Respiratory Disorders). Data collection ran from November 2020 to July 2021.
- Analysis: Interviews/focus groups were recorded over Zoom, transcribed, and analysed using codebook thematic analysis in NVivo v12; 4 transcripts were double-coded during framework development.
## Limitations
- The paper states there was not equal representation across participant groups/specialties, and some specialties had larger participant numbers than others.
- The authors say they were unable to achieve diversity with regards to ethnicity despite aiming for maximum variation.
- The text says all interviews and focus groups were conducted online, which likely limited participation to people familiar with video conferencing and may not represent people less comfortable with online methods.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
24 Valid · 2 Not valid · 13 Not checked · 94 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies operating during the paused phase struggled to recruit and retain study participants [1].”
§ Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio > Introduction
What the sources say
- Partly supportedcites [1] D Wyatt, 2021, Impacts of COVID-19 on clinical research in the UK: a multi-method qualitative case study, PLoS One sourceExperimental — accuracy not yet measured
The Results sections on research prioritisation and the pace of work report that recruitment was paused for many studies and remained slow to recover. The section on virtual working describes disrupted participant visits, but says many studies maintained some continuity through remote follow-up; it does not establish that they struggled to retain participants. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Trust could be increased by prospectively informing patients of changes to research protocols following the Covid-19 pandemic, such as paused, remote, or delayed study visits [16].”
§ Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio > Discussion > Building trust through communication
What the sources say
- Supportedcites [16] M Mourad, 2020, Conducting research during the COVID-19 pandemic., Semin Perinatol source
The Research participants section directly says trust is maximized when participants in ongoing clinical trials are prospectively informed of SARS-CoV-2-related protocol changes, including paused, remote, or delayed study visits. The claim closely paraphrases that passage. (LLM, conf=0.94)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, participants in an oncology trial were incentivised to attend imaging sessions during Covid-19 by the offer of a structured and timely virtual review of their images [17].”
§ Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio > Discussion > A move to remote methods of engagement
What the sources say
- Partly supportedcites [17] CM Deroose, 2020, Impact of the COVID-19 crisis on imaging in oncological trials, Eur J Nucl Med Mol Imaging sourceExperimental — accuracy not yet measured
The Patient perspective section proposes using telemedicine and communicating a structured, timely review of imaging findings to encourage trial imaging attendance. It does not report that participants in a particular oncology trial were actually offered a virtual review or incentivised by one; its wording is prospective ('could' and 'would'). (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, many trial participants and PPIE contributors had a great deal of trust in their clinical team and their decisions around when it was safe for them to visit clinical settings.”
§ Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio > Results > Theme 1: Ensuring continued contact
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Contact was usually achieved through telephone calls, emails, texts, and postal letters”
§ Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio > Results > Theme 1: Ensuring continued contact
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
39 more claims
Create a free account to see all 133 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 65
- It may state two separate claims as one. 49
Citations
Cites
Braun, V., & Clarke, V. (2021) · Qualitative Research in Sport, Exercise and Health · doi:10.1080/2159676x.2019.1704846 · Cited by 4,776 · cited 1×
“In keeping with current methodological guidance, we aimed for maximum variation in our sample, rather than saturation [10].”
Conceptual and design thinking for thematic analysis.
Braun, V., & Clarke, V. (2022) · Qualitative Psychology · doi:10.1037/qup0000196 · Cited by 4,502
Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Review Panel
Mossa-Basha, M., Meltzer, C. C., Kim, D. C., Tuite, M. J., Kolli, K. P., & Tan, B. S. (2020) · Radiology · doi:10.1148/radiol.2020200988 · Cited by 324
Informed Consent for Clinical Trials: a Comparative Study of Standard Versus Simplified Forms
Davis, T. C., Berkel, H. J., Holcombe, R. F., Pramanik, S., & Divers, S. G. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.668 · Cited by 289
Sheridan, R., Martin-Kerry, J., Hudson, J., Parker, A., Bower, P., & Knapp, P. (2020) · Trials · doi:10.1186/s13063-020-4197-3 · Cited by 223 · cited 1×
“Sheridan (2020) and colleagues noted that research participation, even before the onset of Covid-19, had a low uptake [6].”
Boehm, K., Ziewers, S., Brandt, M. P., Sparwasser, P., Haack, M., Willems, F., Thomas, A., Dotzauer, R., Höfner, T., Tsaur, I., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.04.055 · Cited by 193 · cited 1×
“Boehm et al. [21] found that while there was a strong preference for video conferencing during the Covid-19 pandemic, a proportion would decline this due to technical limitations (17.3”
InfluentialUsing Animated Videos to Increase Patient Knowledge: A Meta-Analytic Review.
Feeley, T. H., Keller, M., & Kayler, L. (2023) · Health Education & Behavior · doi:10.1177/10901981221116791 · Cited by 85
Goh, Y., Chua, W., Lee, J. K. T., Ang, B. W. L., Liang, C. R., Tan, C. A., Choong, D. A. W., Hoon, H. X., Ong, M. K. L., & Quek, S. T. (2020) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2020.03.027 · Cited by 73 · cited 1×
“Trial staff may be able to reassure participants by sharing various safety measures such as body temperature checks, social distancing measures, hand sanitisation, surgical masks and one-way systems [25,26].”
The effect of state-level stay-at-home orders on COVID-19 infection rates
Castillo, R. C., Staguhn, E. D., & Weston-Farber, E. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.05.017 · Cited by 66
Auchus, I. C., Jaradeh, K., Tang, A., Marzan, J., & Boslett, B. (2021) · AIDS Patient Care and STDs · doi:10.1089/apc.2021.0075 · Cited by 63 · cited 1×
“Auchus and colleagues [20] found that while remote consultations may increase the likelihood of people attending appointments during a pandemic because they feel safer, there are challenges around technical issues, unfamil-iarity, communication and a lack of human contact and connection.”
Cardel, M. I., Manasse, S., Krukowski, R. A., Ross, K., Shakour, R., Miller, D. R., Lemas, D. J., & Hong, Y. (2020) · Obesity · doi:10.1002/oby.23016 · Cited by 59 · cited 1×
“This hesitancy to participate in research has been compounded, especially if in-person visits to a clinical setting were required [7] Concerns during the pandemic included: [1] difficulties attending trial sessions due to reduced public transport or not wanting to use public transport, [8]…”
Dellson, P., Nilsson, K., Jernström, H., & Carlsson, C. (2018) · Trials · doi:10.1186/s13063-018-2916-9 · Cited by 58 · cited 1×
“This finding mirrors why people decide to take part in trials in the first place, as trust in healthcare professionals makes patients feel safe and secure when deciding to sign up for a trial [13].”
Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials.
Fleury, M. E., Farner, A. M., & Unger, J. M. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.5748 · Cited by 50
The impact of COVID-19 on the clinical trial.
Chen, Z., Chen, L., & Chen, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251410 · Cited by 43 · cited 1×
“…reduced public transport or not wanting to use public transport, [8] difficulties understanding safety protocols or perceptions that health sites were not stringent enough and [2] worry that visiting health settings could pose a threat to the participant’s health from infection of Covid-19 [6,9].”
Conducting research during the COVID-19 pandemic.
Mourad, M., Bousleiman, S., Wapner, R., & Gyamfi-Bannerman, C. (2020) · Seminars in Perinatology · doi:10.1016/j.semperi.2020.151287 · Cited by 42
COVID-19: the relationship between perceptions of risk and behaviours during lockdown
Brown, R., Coventry, L., & Pepper, G. V. (2021) · Journal of Public Health · doi:10.1007/s10389-021-01543-9 · Cited by 39
Gobat, N., Butler, C. C., Mollison, J., Francis, N. A., Gal, M., Harris, V., Webb, S. A. R., Byrne, J.-P., Watkins, A., Sukumar, P., et al. (2019) · Public Health · doi:10.1016/j.puhe.2019.07.005 · Cited by 36
Participant and Caregiver Perspectives on Clinical Research During Covid-19 Pandemic.
Padala, P. R., Jendro, A. M., Gauss, C. H., Orr, L. C., Dean, K. T., Wilson, K. B., Parkes, C. M., & Padala, K. P. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16500 · Cited by 35
Viale, G., Licata, L., Sica, L., Zambelli, S., Zucchinelli, P., Rognone, A., Aldrighetti, D., Di Micco, R., Zuber, V., Pasetti, M., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0316 · Cited by 35
Impacts of COVID-19 on clinical research in the UK: a multi-method qualitative case study
Wyatt, D., Faulkner-Gurstein, R., Cowan, H., & Wolfe, C. D. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256871 · Cited by 35
Optimizing the Communication with Cancer Patients During the COVID-19 Pandemic: Patient Perspectives
Tashkandi, E., BaAbdullah, M., Zeeneldin, A., AlAbdulwahab, A., Elemam, O., Elsamany, S., Alfayez, M., Dabash, Y., Khayat, E., Hassanin, F., et al. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s263022 · Cited by 30 · cited 1×
“For example, Tashkandi et al [14] found that cancer patients’ preferred communication method during the Covid-19 pandemic was a telephone call, which the authors attributed to trust and reassurance in the established relationship with their oncologist.”
Vissers, M. F. J. M., Cohen, A. F., Van Gerven, J. M. A., & Groeneveld, G. J. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14480 · Cited by 25
Gerber, D. E., Sheffield, T. Y., Beg, M. S., Williams, E. L., Clark, V. L., Xie, Y., Holbein, M. E. B., Skinner, C. S., & Lee, S. J. C. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7643 · Cited by 23 · cited 1×
“…office personnel assessing perceptions, experiences and recommendations related to Covid-19 adjustments to trials found a perceived improvement in communication with participants, investigators and sponsors, patient safety, treatment efficacy, and the experience of both participants and staff [19].”
Animations about Clinical Trial Participation for Cancer Patients and Survivors
Occa, A., & Morgan, S. E. (2019) · Journal of Health Communication · doi:10.1080/10810730.2019.1668089 · Cited by 19
Nguyen, V. T., Ravaud, P., Tran, V. T., Young, B., & Boutron, I. (2022) · Journal of Medical Internet Research · doi:10.2196/29691 · Cited by 17 · cited 2×
“This is supported by a vignette-based study that asked participants their preferences for trial organisation and delivery [18].”
Impact of the COVID-19 crisis on imaging in oncological trials
Deroose, C. M., Lecouvet, F. E., Collette, L., Oprea-Lager, D. E., Kunz, W. G., Bidaut, L., Verhoeff, J. J. C., Caramella, C., Lopci, E., Tombal, B., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04910-y · Cited by 12
COVID-19: the relationship between perceptions of risk and behaviours during lockdownPreprint
Brown, R. D., Coventry, L., & Pepper, G. V. (2020) · doi:10.31219/osf.io/dwjvy · Cited by 10
Research works printed but not linked: 4
- 2020, NIHR shares first update on implementation of the Restart Framework
- National Institute for Health Research, DHSC issues guidance on the impact of COVID-19 on research funded or supported by NIHR 16/03/21
- 2022, Timeline of UK government coronavirus lockdowns and measures, March 2020 to December 2021, Institute for Government analysis
- 2021, NIHR issues final update on implementation of the Restart Framework
Cited by
Aiyegbusi, O. L., McMullan, C., Hughes, S., Turner, G., Haroon, S. M., Hotham, R., Brown, K. R., Alder, Y., Agyen, L., Buckland, L., et al. (2024) · Research Involvement and Engagement · doi:10.1186/s40900-024-00654-3 · Cited by 10
“For instance, Leggett et al. [38] highlighted the need for patient input in the design of participant information sheets.”
BackgroundSafety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico
Rosas-Guzmán, J., Navarro‐Lara, A., Sañudo‐Maury, M. E., Anguiano, L., & Sauque‐Reyna, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16357 · Cited by 2
Future‐Proofing Dentistry: A Qualitative Exploration of COVID ‐19 Responses in UK Dental Schools
Vernon, J. J., Vinall‐Collier, K. A., Csikar, J. I., Emms, G., Lancaster, P. E., Nattress, B. R., & Wood, D. J. (2024) · European Journal Of Dental Education · doi:10.1111/eje.13055
Self-citationDevelopment of a clinical trial knowledge management application for community oncology
O'Brien, E., Thumar, A., Manning, M., Gunturu, K. S., Yu, P. P., & Hung, T. K. W. (2026) · JAMIA Open · doi:10.1093/jamiaopen/ooag140
Metadata
- Authors
- Leggett, H., Vinall-Collier, K., Csikar, J., Barber, S., Carr, R., Bhatti, A., & Pavitt, S.
- Affiliations
- University of York (GB)
- University of Leeds (GB)
- Corresponding author
- Leggett, Heather
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2024-02-21
- Volume
- 19
- Issue
- 2
- Pages
- e0296343
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC10880997
- OpenAlex
- W4391993616
- Cited by
- 4
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NIHR Yorkshire and Humber strategic funding (2021-014-HEICOVID & Us - VACCINE & Restart.)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Keywords
- COVID-19 pandemic, clinical trial participation, trial retention, patient and public involvement, trial participants, teleconsultation, participant communication, informed consent, research disruption, pandemic preparedness, NIHR
- MeSH terms
- COVID-19, Aged, Clinical Trials as Topic, Communication, Humans, Focus Groups, Trust, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

